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Hypereosinophilic syndrome (HES) comprises a group 
of rare disorders characterized by persistence of blood 
hypereosinophilia (> 1500 mm–3) for > 6 months; and 
definite signs of organ involvement without the secondary 
causes of eosinophilia (1). Cutaneous findings are present 
in up to 50% of patients with HES, e.g. pruritic papules, 
eczema-like patches, urticarial plaques, and angioedema 
(1). In HES patients, occlusions of intermediate- to large-
sized arteries frequently cause peripheral ischaemia and 
even digital gangrene (2–6). Digital necrosis without 
evidence for vascular occlusion has rarely been described 
in patients with HES (7). We report here a case of HES 
complicated by severe digital gangrene without angio-
graphic evidence of occlusion of peripheral arteries, but 
with histopathological evidence of occlusion of cutaneous 
small vessels by micro-thrombi.
CASE REPORT
A 41-year-old Korean man presented with a 3-month history 
of painless digital gangrene and bony exposures on the distal 
fingers (Fig. 1a). The patient had a smoking history of 15 
pack-years (1 pack/day for 15 years) and had had Raynaud’s 
phenomenon for the past 9 months. An elevation of peripheral 
eosinophil count one year before his presentation was noted in 
his medical history. On physical examination, brownish eczema-
like patches and lichenified changes were noted on all extre-
mities (Fig. 1b). A 3-mm punch biopsy from the arm revealed 
marked infiltration of eosinophils throughout the lower dermis 
and subcutaneous fat layer (Fig. 2a). In addition, necrotizing 
eosinophilic vasculitis of a dermal vessel and prominent lumi-
nal micro-thrombus were observed (Fig. 2b). Initial laboratory 
investigation revealed an increase in white blood cell count 
(19,270 mm–3) with severe hypereosinophilia (9,980 mm–3, 
49% of total leukocytes) and an elevation in serum eosinophil 
cationic protein (ECP) (> 200 μg/l). Stool parasite examination, 
serum anti-neutrophil cytoplasmic antibodies, and anti-nuclear 
antibodies were all negative. Ground-glass opacities on both 
lower lung fields were noted via chest computed tomography 
(CT), corresponding to a decrease in diffusion lung capacity by 
82%. CT-angiographic study of the upper extremities revealed 
no evidence for occlusion of any of digital arteries or large 
vessels. We initially decided to treat the patient with systemic 
corticosteroid; however, he refused all treatments and bone 
marrow biopsy for further evaluation.
DISCUSSION
HES encompasses a spectrum of diseases, which can 
be classified into several variants (8).
Digital necrosis is a rare complication in HES. In a 
previous case series, Kawata et al. (9) suggested that 
such gangrene could result from a thromboangiitis 
obliterans (TAO)-like artery occlusion with male pre-
ponderance; but no higher rate of occurrence in smokers 
than non-smokers (9). In our patient, the angiographic 
study revealed no evidence of large-vessel occlusion, 
suggesting an involvement of smaller vessels instead. 
In line with this, we found a promi-
nent micro-thrombus packing the 
vasculature of the lower dermis. The 
underlying mechanism for vascular th-
rombus formation in HES is currently 
poorly understood. Previously, it was 
shown that cytotoxic ECP could play 
a role in the inhibition of a specific 
anticoagulant, thrombomodulin. The 
inhibited activity of thrombomodulin 
was related to the thromboembolism 
found in eosinophilic endocarditis 
(10). In addition, ECP seemed to par-
ticipate in eosinophil-induced vascular 
injury (11), and smoking history was 
associated with an elevated serum ECP 
level, which might in turn accelerate 
vascular damage (12). Together, an 
increase in serum ECP level in our 
case might influence further micro-
vascular injury, leading to severe 
digital gangrene.
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Fig. 1. (a) Digital necrosis with bony exposures on the finger-tips. (b) Brownish eczema-like patches 
and lichenified changes were noted on the left leg and other extremities.
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True TAO, characterized by painful ulcers on the acral 
areas should be differentiated. Vascular abnormalities 
revealed on the imaging studies may not be a useful clue 
in differentiating TAO from TAO-like occlusion in HES 
(3, 5, 9). Typical pain occurring in patients with TAO 
may be a differential point, as necrosis in HES can be 
painless, as in our patient. Furthermore, histopathologi-
cal findings of marked infiltration of eosinophils in HES 
can easily distinguish it from true TAO, where mixed-
cellular infiltration is characteristic (13). Necrotizing 
eosinophilic vasculitis found in HES can also serve as 
differentiating clue (2, 14, 15). 
Systemic corticosteroid is the treatment of choice for 
HES with the exception of FIP1L1-PDGFRA-positive 
myeloproliferative HES and chronic eosinophilic leu-
kaemia, where imatinib mesylate is the first-line option 
(1, 8). However, digital gangrene in HES has been re-
ported to be poorly responsive to corticosteroid therapy 
(5, 7). Vascular angioplasty combined with the use of 
anticoagulants and systemic corticosteroid showed a 
successful treatment outcome in a patient with arterial 
occlusion-associated digital necrosis in HES (9). How-
ever, vascular intervention cannot be employed without 
evidence of definite arterial occlusion. Discontinuation 
of tobacco use may be the definitive therapy, as in the 
case of TAO (13).
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Fig. 2. (a) Marked infiltrate of 
eosinophils throughout the lower 
dermis and subcutaneous fat 
layer (haematoxylin-eosin (H&E) 
stain; original magnification: × 40). 
(b) Fibrinoid change in the vessel 
wall and prominent luminal 
micro-thrombus with surrounding 
eosinophils were noted. (H&E; 
original magnification: × 200).
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